Ignite Creation Date:
2024-10-26 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 3:42 PM
Study NCT ID:
NCT06636552
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-09-09
Brief Title:
An Investigator-Initiated Phase II Multicenter Open-Label Single-Arm Prospective Clinical Trial to Evaluate the Efficacy and Safety of Alternating Bortezomib-Based Regimens in Combination With DaratUMumab Followed by Maintenance With Daratumumab in the Frontline Setting of Primary Plasma CEll L
Sponsor:
Organization:
None